PGV prevalence was assessed for 682 BRs of 281 probands with BRCA1/BRCA2 wild-type hereditary breast and ovarian cancer (HBOC) syndrome. Here, BRCA2 is linked to Hereditary breast and ovarian cancer syndrome.